Research design topics gathered here
Despite its name, this category currently holds articles on how clinical and translational research is designed and analysed, the groundwork that determines whether findings will be credible enough to promote at all. The five pieces listed above cover the statistical analysis of case-control studies, epidemiological designs used in clinical trials, health economics alongside trials, the selection of excipients, active ingredients and packaging in drug development, and examples of gene therapy work handled by clinical research organisations.
How the articles connect
Read together, the articles follow a product or intervention from development to evaluation:
- Development: the material selection article classifies excipients and discusses active pharmaceutical ingredients and packaging, where stability, compatibility and regulatory acceptability guide each choice; the gene therapy piece gives examples of work handled by clinical research organisations, a field where vector choice, manufacturing and long-term follow-up shape trial design.
- Design: the epidemiology article sets clinical trials alongside observational designs, which differ in their exposure to bias, cost and time to results.
- Analysis: the case-control article covers study design, the selection of cases and recent research using these analyses. In practice, matched designs call for conditional logistic regression, and the odds ratio is the usual measure of association.
- Value: the health economics article draws on an ISPOR report to explain how cost and outcome data collected within a trial support economic evaluation, which is typically reported in line with the CHEERS statement.
Using these pieces in a project
At the protocol stage, the design and economics articles help a team decide what data to collect, since resource-use and quality-of-life measures cannot be added retrospectively. During analysis, the case-control article is a useful check that the chosen model reflects the matching used at recruitment. When writing up, the relevant reporting guideline (STROBE for observational studies, CONSORT for trials, CHEERS for economic evaluations) will set out what readers and reviewers expect to see.
Once a study is published, wider visibility depends on clear communication: plain-language summaries, graphical abstracts and accurate press material. Our separate research promotion category and the research impact services deal with that stage.
Promotion works best when it is planned alongside the study rather than after publication. Registering the protocol, sharing a preprint where the target journal permits it, and depositing data in a recognised repository all make a study easier to find and cite, and each depends on decisions taken early in the project.
Further support for study design and analysis
For help planning a study, see experimental design; for analysis plans and statistical programming, biostatistics services; and for economic evaluation, health economics and outcomes research.


